Updated September 2026Sale-dependent headlineBetterMe Rx review
The advertised rate holds while a sitewide sale runs, and the pricing page carries no notice of what happens when it stops.
The verdict
BetterMe Rx puts two numbers on the same page for the same product and never says which one a buyer will meet. The advertised rate holds only while a sitewide sale runs; the undiscounted rate is printed beside it, fifty dollars a month higher. Publishing both is more honest than most sellers manage. Saying nothing about which applies today undoes much of that.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- States
- 50
- Injection
- From $199/mo
- Oral
- From $250/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- 50 states
BetterMe Rx sells compounded semaglutide and compounded tirzepatide across injected and oral forms, stated across fifty states. All four lines are quoted as monthly figures but sold as three-month plans, and every one of those figures depends on a sitewide sale being live at the moment a buyer arrives.
Who writes the prescription, and what do they see?
The prescription is arranged remotely and precedes shipping, and the pages describe plans rather than clinicians. The intake is not documented, so what a prescriber sees before writing is not something a reader can establish from the site. That is common enough here. It sits alongside a pricing structure that already asks for a good deal of trust.
A sale that has run continuously is still a sale, and that is the thing to hold onto. The advertised figure is real while it lasts, the regular figure is also published, and nothing on the pricing page tells a buyer which one will apply on the day they order. The three-month plan then converts whichever rate applies into a single charge at the start.
What happens when the dose goes up?
Nothing is published about what either rate does as the dose rises, and the three-month structure makes that gap wider than it looks. A buyer commits a quarter at one figure, without knowing whether the next quarter carries the same one at a higher dose.
What the price includes
Two conditions sit on every figure and neither is hidden. The first is the sale. The second is the term: a quarter is bought at once, so the opening charge is nearly three times the quoted monthly rate. Both oral lines inherit the same arrangement as their injections. What a reader cannot establish from the pages is the only thing that decides the bill, which is whether the discount is live on the day they order.
What it claims, and what it cites
Every line is compounded, so none has been assessed by the FDA for safety or quality before reaching a buyer. BetterMe Rx does not name the pharmacy that prepares them.
Where it holds up, and where it does not
- Strength: Both rates appear on the same page
- Strength: Coverage is enumerated, not asserted
- Strength: Sale condition is named in the copy
- Limitation: The page never says which rate applies today
- Limitation: The term is a quarter, not a month
- Limitation: Escalation is undocumented on every line
- Limitation: Last confirmed in July, not since
What the evidence says about this kind of treatment
The assessment above is about BetterMe Rx. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who will confirm the sale is running and is content to commit three months at once.
- Wrong for
- A reader budgeting from the advertised figure without checking which rate applies today.
How BetterMe Rx compares
| Seller | Who it suits | Go |
|---|---|---|
 MadeMed | Readers ready to commit six months, which is what the advertised figure assumes | See MadeMed → |
| GobyMeds | Readers who can pay twelve weeks at once and want the extras inside one figure | See GobyMeds → |
 Lttl | Readers who want every prepay rung visible and know which dose line they need | See Lttl → |
More GLP-1 telehealth sellers reviews: LibertyLifeMDLuvo HealthMaximusMEDGmNEUVÉ Health
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Is $199 the real price?
- Only while a sitewide sale is running. The undiscounted rate is published alongside it and is fifty dollars a month higher, read July 2026.
- Is billing monthly?
- No. A quarter is purchased at once, so the first charge is close to three times the figure quoted as monthly.
- What does half a year cost?
- It depends entirely on whether the sale is live when you order, and the pricing page gives a reader no way to tell.
- Is BetterMe Rx legit?
- BetterMe Rx is a GLP-1 telehealth sellers service. Its stated availability: 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is BetterMe Rx expensive compared with other GLP-1 telehealth sellers?
- BetterMe Rx publishes a starting figure of $199/mo. Across the 83 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $179, which puts BetterMe Rx above the median. The other 5 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.